{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:00:54Z","timestamp":1793026854709,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41585-024-00992-7","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:39:36Z","timestamp":1738085976000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epidemiology, diagnosis and treatment of anterior prostate cancer"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-1191","authenticated-orcid":false,"given":"Sammy","family":"Gharbieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata","family":"Jaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Challacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"992_CR1","unstructured":"Cancer Research UK. Prostate cancer statistics. Cancer Research UKhttps:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer (2024)."},{"key":"992_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal, J. E. Normal histology of the prostate. Am. J. Surg. Pathol. 12, 619\u2013633 (1988).","journal-title":"Am. J. Surg. Pathol."},{"key":"992_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pros.2990020105","volume":"2","author":"JE McNeal","year":"1981","unstructured":"McNeal, J. E. The zonal anatomy of the prostate. Prostate 2, 35\u201349 (1981).","journal-title":"Prostate"},{"key":"992_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1259\/bjr\/56357549","volume":"85","author":"CJ Harvey","year":"2012","unstructured":"Harvey, C. J., Pilcher, J., Richenberg, J., Patel, U. & Frauscher, F. Applications of transrectal ultrasound in prostate cancer. Br. J. Radiol. 85, S3\u2013S17 (2012).","journal-title":"Br. J. Radiol."},{"key":"992_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.urology.2014.12.035","volume":"85","author":"GA Abdelsayed","year":"2015","unstructured":"Abdelsayed, G. A., Danial, T., Kaswick, J. A. & Finley, D. S. Tumors of the anterior prostate: implications for diagnosis and treatment. Urology 85, 1224\u20131228 (2015).","journal-title":"Urology"},{"key":"992_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41391-019-0199-1","volume":"23","author":"SM Falzarano","year":"2020","unstructured":"Falzarano, S. M. et al. Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment. Prostate Cancer Prostatic Dis. 23, 435\u2013440 (2020).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"992_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal, J. E., Redwine, E. A., Freiha, F. S. & Stamey, T. A. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 12, 897\u2013906 (1988).","journal-title":"Am. J. Surg. Pathol."},{"key":"992_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/PAS.0000000000002042","volume":"47","author":"H Samaratunga","year":"2023","unstructured":"Samaratunga, H. et al. Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging. Am. J. Surg. Pathol. 47, 701\u2013708 (2023).","journal-title":"Am. J. Surg. Pathol."},{"key":"992_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1046\/j.1464-410X.2002.02796.x","volume":"89","author":"SRJ Bott","year":"2002","unstructured":"Bott, S. R. J., Young, M. P. A., Kellett, M. J. & Parkinson, M. C. Anterior prostate cancer: is it more difficult to diagnose? BJU Int. 89, 886\u2013889 (2002).","journal-title":"BJU Int."},{"key":"992_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.juro.2016.03.075","volume":"196","author":"M Kim","year":"2016","unstructured":"Kim, M. et al. Characteristics of anteriorly located prostate cancer and the usefulness of multiparametric magnetic resonance imaging for diagnosis. J. Urol. 196, 367\u2013373 (2016).","journal-title":"J. Urol."},{"key":"992_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2016.08.057","volume":"72","author":"A Villers","year":"2017","unstructured":"Villers, A. et al. Partial prostatectomy for anterior cancer: short-term oncologic and functional outcomes. Eur. Urol. 72, 333\u2013342 (2017).","journal-title":"Eur. Urol."},{"key":"992_CR12","first-page":"6897","volume":"20","author":"PN Werahera","year":"2013","unstructured":"Werahera, P. N. et al. Anterior tumors of the prostate: diagnosis and significance. Can. J. Urol. 20, 6897\u20136906 (2013).","journal-title":"Can. J. Urol."},{"key":"992_CR13","doi-asserted-by":"publisher","first-page":"E267","DOI":"10.5489\/cuaj.2562","volume":"9","author":"G Al Edwan","year":"2015","unstructured":"Al Edwan, G. et al. Magnetic resonance imaging detected prostate evasive anterior tumours: further insights. Can. Urol. Assoc. J. 9, E267\u2013E272 (2015).","journal-title":"Can. Urol. Assoc. J."},{"key":"992_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/bco2.202","volume":"4","author":"R Saghir","year":"2022","unstructured":"Saghir, R. et al. Clinical outcomes of anterior prostate cancers treated with robotic assisted radical prostatectomy. BJUI Compass 4, 352\u2013360 (2022).","journal-title":"BJUI Compass"},{"key":"992_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1516","volume":"7","author":"HD Patel","year":"2024","unstructured":"Patel, H. D. et al. Comparison of magnetic resonance imaging-based risk calculators to predict prostate cancer risk. JAMA Netw. Open 7, e241516 (2024).","journal-title":"JAMA Netw. Open"},{"key":"992_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.02.1677","volume":"199","author":"G Marcq","year":"2018","unstructured":"Marcq, G. et al. Prevalence and pathological characteristics of anterior prostate cancer in a cohort of radical prostatectomy patients diagnosed by biopsies and MRI. J. Urol. 199, e706 (2018).","journal-title":"J. Urol."},{"key":"992_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/pcan.2013.54","volume":"17","author":"J Mygatt","year":"2014","unstructured":"Mygatt, J. et al. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer Prostatic Dis. 17, 75\u201380 (2014).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"992_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1464-410X.2006.06578.x","volume":"98","author":"TM Koppie","year":"2006","unstructured":"Koppie, T. M. et al. The clinical features of anterior prostate cancers. BJU Int. 98, 1167\u20131171 (2006).","journal-title":"BJU Int."},{"key":"992_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona, W. J. et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 324, 1156\u20131161 (1991).","journal-title":"N. Engl. J. Med."},{"key":"992_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-018-0765-y","volume":"19","author":"D Jones","year":"2018","unstructured":"Jones, D., Friend, C., Dreher, A., Allgar, V. & Macleod, U. The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: a systematic review. BMC Fam. Pract. 19, 1\u20136 (2018).","journal-title":"BMC Fam. Pract."},{"key":"992_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss, M. A. et al. An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J. Urol. 198, 329\u2013334 (2017).","journal-title":"J. Urol."},{"key":"992_CR22","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.juro.2013.02.072","volume":"189","author":"MA Bjurlin","year":"2013","unstructured":"Bjurlin, M. A. et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J. Urol. 189, 2039\u20132046 (2013).","journal-title":"J. Urol."},{"key":"992_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.eururo.2011.05.006","volume":"60","author":"G Ploussard","year":"2011","unstructured":"Ploussard, G. et al. The contemporary concept of significant versus insignificant prostate cancer. Eur. Urol. 60, 291\u2013303 (2011).","journal-title":"Eur. Urol."},{"key":"992_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","volume":"65","author":"S Loeb","year":"2014","unstructured":"Loeb, S. et al. Overdiagnosis and overtreatment of prostate cancer. Eur. Urol. 65, 1046\u20131055 (2014).","journal-title":"Eur. Urol."},{"key":"992_CR25","doi-asserted-by":"publisher","first-page":"20210413","DOI":"10.1259\/bjr.20210413","volume":"95","author":"S Ippoliti","year":"2022","unstructured":"Ippoliti, S. et al. Optimal biopsy approach for detection of clinically significant prostate cancer. Br. J. Radiol. 95, 20210413 (2022).","journal-title":"Br. J. Radiol."},{"key":"992_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","volume":"17","author":"A Stabile","year":"2019","unstructured":"Stabile, A. et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat. Rev. Urol. 17, 41\u201361 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"992_CR27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","volume":"67","author":"EH Hamoen","year":"2015","unstructured":"Hamoen, E. H., de Rooij, M., Witjes, J. A., Barentsz, J. O. & Rovers, M. M. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur. Urol. 67, 1112\u20131121 (2015).","journal-title":"Eur. Urol."},{"key":"992_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.eururo.2017.02.026","volume":"72","author":"PC Moldovan","year":"2017","unstructured":"Moldovan, P. C. et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur. Urol. 72, 250\u2013266 (2017).","journal-title":"Eur. Urol."},{"key":"992_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6434-2","volume":"19","author":"L Zhen","year":"2019","unstructured":"Zhen, L. et al. Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate cancer: a systematic review and meta-analysis. BMC Cancer 19, 1\u201315 (2019).","journal-title":"BMC Cancer"},{"key":"992_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen, N. J. et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur. Urol. 78, 402\u2013414 (2020).","journal-title":"Eur. Urol."},{"key":"992_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.juro.2013.03.078","volume":"190","author":"Y Komai","year":"2013","unstructured":"Komai, Y. et al. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J. Urol. 190, 867\u2013873 (2013).","journal-title":"J. Urol."},{"key":"992_CR32","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.1111\/bju.12670","volume":"114","author":"D Volkin","year":"2014","unstructured":"Volkin, D. et al. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI\/ultrasonography fusion\u2010guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int. 114, E43\u2013E49 (2014).","journal-title":"BJU Int."},{"key":"992_CR33","doi-asserted-by":"publisher","first-page":"W185","DOI":"10.2214\/AJR.14.13392","volume":"205","author":"H Shinmoto","year":"2015","unstructured":"Shinmoto, H. et al. Anterior prostate cancer: diagnostic performance of T2-weighted MRI and an apparent diffusion coefficient map. Am. J. Roentgenol. 205, W185\u2013W192 (2015).","journal-title":"Am. J. Roentgenol."},{"key":"992_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.urology.2010.12.067","volume":"77","author":"OM Zaytoun","year":"2011","unstructured":"Zaytoun, O. M. et al. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77, 1035\u20131041 (2011).","journal-title":"Urology"},{"key":"992_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","volume":"183","author":"RK Nam","year":"2010","unstructured":"Nam, R. K. et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J. Urol. 183, 963\u2013969 (2010).","journal-title":"J. Urol."},{"key":"992_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrurol.2013.195","volume":"10","author":"DTS Chang","year":"2013","unstructured":"Chang, D. T. S., Challacombe, B. & Lawrentschuk, N. Transperineal biopsy of the prostate \u2014 is this the future? Nat. Rev. Urol. 10, 690\u2013702 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"992_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","volume":"20","author":"MJ Connor","year":"2023","unstructured":"Connor, M. J. et al. Landmarks in the evolution of prostate biopsy. Nat. Rev. Urol. 20, 241\u2013258 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"992_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","volume":"71","author":"MG Schouten","year":"2017","unstructured":"Schouten, M. G. et al. Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-na\u00efve men? Eur. Urol. 71, 896\u2013903 (2017).","journal-title":"Eur. Urol."},{"key":"992_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/JU.0000000000002251","volume":"207","author":"D Castellani","year":"2022","unstructured":"Castellani, D. et al. Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a systematic review and meta-analysis of comparative studies. J. Urol. 207, 25\u201334 (2022).","journal-title":"J. Urol."},{"key":"992_CR40","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.5152\/tud.2020.20358","volume":"47","author":"G Ortner","year":"2021","unstructured":"Ortner, G., Tzanaki, E., Rai, B. P., Nagele, U. & Tokas, T. Transperineal prostate biopsy: the modern gold standard to prostate cancer diagnosis. Turkish J. Urol. 47, S19\u2013S26 (2021).","journal-title":"Turkish J. Urol."},{"key":"992_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.juro.2012.05.006","volume":"188","author":"T Hossack","year":"2012","unstructured":"Hossack, T. et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J. Urol. 188, 781\u2013785 (2012).","journal-title":"J. Urol."},{"key":"992_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1464-410X.2011.10355.x","volume":"109","author":"RP Pal","year":"2012","unstructured":"Pal, R. P., Elmussareh, M., Chanawani, M. & Khan, M. A. The role of a standardized 36 core template\u2010assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography\u2010guided prostate biopsies. BJU Int. 109, 367\u2013371 (2012).","journal-title":"BJU Int."},{"key":"992_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.eururo.2007.02.041","volume":"52","author":"GS Merrick","year":"2007","unstructured":"Merrick, G. S. et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur. Urol. 52, 715\u2013724 (2007).","journal-title":"Eur. Urol."},{"key":"992_CR44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1464-410X.2012.10972.x","volume":"110","author":"NJ Mabjeesh","year":"2012","unstructured":"Mabjeesh, N. J., Lidawi, G., Chen, J., German, L. & Matzkin, H. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound\u2010guided template saturation biopsy. BJU Int. 110, 993\u2013997 (2012).","journal-title":"BJU Int."},{"key":"992_CR45","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.urolonc.2012.01.001","volume":"31","author":"B Gershman","year":"2013","unstructured":"Gershman, B., Zietman, A. L., Feldman, A. S. & McDougal, W. S. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol. Oncol. 31, 1093\u20131097 (2013).","journal-title":"Urol. Oncol."},{"key":"992_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/pcan.2009.42","volume":"13","author":"AV Taira","year":"2010","unstructured":"Taira, A. V. et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 13, 71\u201377 (2010).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"992_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-022-00670-6","volume":"20","author":"MJ Roberts","year":"2023","unstructured":"Roberts, M. J. et al. Using PSMA imaging for prognostication in localized and advanced prostate cancer. Nat. Rev. Urol. 20, 23\u201347 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"992_CR48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","volume":"70","author":"M Perera","year":"2020","unstructured":"Perera, M. et al. Sensitivity, specificity, and predictors of positive 68 Ga\u2013prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur. Urol. 70, 926\u2013937 (2020).","journal-title":"Eur. Urol."},{"key":"992_CR49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.2020.38.15_suppl.5500","volume":"38","author":"MS Hofman","year":"2020","unstructured":"Hofman, M. S. et al. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, management decisions, and their impact. J. Clin. Oncol. 38, 400\u2013409 (2020).","journal-title":"J. Clin. Oncol."},{"key":"992_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett, L. et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur. Urol. 80, 682\u2013689 (2021).","journal-title":"Eur. Urol."},{"key":"992_CR51","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1464-410X.2004.05147.x","volume":"94","author":"H Augustin","year":"2004","unstructured":"Augustin, H., Erbersdobler, A., Hammerer, P. G., Graefen, M. & Huland, H. Prostate cancers in the transition zone: part 2; clinical aspects. BJU Int. 94, 1226\u20131229 (2004).","journal-title":"BJU Int."},{"key":"992_CR52","first-page":"267","volume":"19","author":"DJ Grignon","year":"1994","unstructured":"Grignon, D. J. & Sakr, W. A. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J. Cel. Biochem. 19, 267\u2013269 (1994).","journal-title":"J. Cel. Biochem."},{"key":"992_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/pros.22903","volume":"75","author":"JJ Lee","year":"2015","unstructured":"Lee, J. J. et al. Biologic differences between peripheral and transition zone prostate cancer. Prostate 75, 183\u2013190 (2015).","journal-title":"Prostate"},{"key":"992_CR54","first-page":"467","volume":"35","author":"BA Shannon","year":"2003","unstructured":"Shannon, B. A., McNeal, J. E. & Cohen, R. J. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathol 35, 467\u2013471 (2003).","journal-title":"Pathol"},{"key":"992_CR55","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.urolonc.2014.11.005","volume":"33","author":"HS Dev","year":"2015","unstructured":"Dev, H. S. et al. Surgical margin length and location affect recurrence rates after robotic prostatectomy. Urol. Oncol. 33, e7\u2013e13 (2015).","journal-title":"Urol. Oncol."},{"key":"992_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jjco\/hyx039","volume":"47","author":"K Hashimoto","year":"2017","unstructured":"Hashimoto, K., Shinkai, N., Tanaka, T. & Masumori, N. Impact of extended prostate biopsy including apical anterior region for cancer detection and prediction of surgical margin status for radical prostatectomy. Jpn. J. Clin. Oncol. 47, 568\u2013573 (2017).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"992_CR57","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/jmri.25510","volume":"45","author":"N Schieda","year":"2017","unstructured":"Schieda, N. et al. MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysis. J. Magn. Reson. Imaging 45, 1296\u20131303 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"992_CR58","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.21873\/anticanres.15785","volume":"42","author":"P Pepe","year":"2022","unstructured":"Pepe, P. et al. Detection rate of 68Ga-PSMA PET\/CT vs. mpMRI targeted biopsy for clinically significant prostate cancer. Anticancer. Res. 42, 3011\u20133015 (2022).","journal-title":"Anticancer. Res."},{"key":"992_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prnil.2022.07.005","volume":"11","author":"M Oshima","year":"2023","unstructured":"Oshima, M. et al. Retzius-sparing robotic prostatectomy is associated with higher positive surgical margin rate in anterior tumors, but not in posterior tumors, compared to conventional anterior robotic prostatectomy. Prostate Int. 11, 13\u201319 (2023).","journal-title":"Prostate Int."},{"key":"992_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/JU.0000000000000461","volume":"203","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Retzius sparing robot-assisted radical prostatectomy conveys early regain of continence over conventional robot-assisted radical prostatectomy: a propensity score matched analysis of 1,863 patients. J. Urol. 203, 137\u2013144 (2020).","journal-title":"J. Urol."},{"key":"992_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bju.15311","volume":"128","author":"A Mottrie","year":"2021","unstructured":"Mottrie, A. et al. Objective assessment of intraoperative skills for robot\u2010assisted radical prostatectomy (RARP): results from the ERUS scientific and educational working groups metrics initiative. BJU Int. 128, 103\u2013111 (2021).","journal-title":"BJU Int."},{"key":"992_CR62","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41391-023-00698-8","volume":"27","author":"R Nicoletti","year":"2024","unstructured":"Nicoletti, R. et al. Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs). Prostate Cancer Prostatic Dis. 27, 614\u2013622 (2024).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"992_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken, J. S. et al. An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years? Eur. Urol. 81, 5\u201333 (2022).","journal-title":"Eur. Urol."},{"key":"992_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.diii.2018.03.001","volume":"99","author":"IS Elhelf","year":"2018","unstructured":"Elhelf, I. S. et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn. Interv. Imaging 99, 349\u2013359 (2018).","journal-title":"Diagn. Interv. Imaging"},{"key":"992_CR65","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00345-020-03297-7","volume":"39","author":"PM Huber","year":"2021","unstructured":"Huber, P. M. et al. Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. World J. Urol. 39, 1115\u20131119 (2021).","journal-title":"World J. Urol."},{"key":"992_CR66","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.urolonc.2019.09.001","volume":"38","author":"FA Schmid","year":"2019","unstructured":"Schmid, F. A. et al. Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: safety outcomes and complications. Urol. Oncol. 38, 225\u2013230 (2019).","journal-title":"Urol. Oncol."},{"key":"992_CR67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41391-018-0042-0","volume":"21","author":"R Ganzer","year":"2018","unstructured":"Ganzer, R. et al. Which technology to select for primary focal treatment of prostate cancer? \u2014 European Section of Urotechnology (ESUT) position statement. Prostate Cancer Prostatic Dis. 21, 175\u2013186 (2018).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"992_CR68","first-page":"317","volume":"69","author":"KJ Tay","year":"2016","unstructured":"Tay, K. J. & Polascik, T. J. Focal cryotherapy for localized prostate cancer. Arch. Esp. Urol. 69, 317\u2013326 (2016).","journal-title":"Arch. Esp. Urol."},{"key":"992_CR69","first-page":"CD005010","volume":"5","author":"JH Jung","year":"2018","unstructured":"Jung, J. H. et al. Primary cryotherapy for localised or locally advanced prostate cancer. Cochrane Database Syst. Rev. 5, CD005010 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"992_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-019-0562-5","volume":"19","author":"C Sze","year":"2019","unstructured":"Sze, C. et al. Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging. BMC Urol. 19, 1\u20137 (2019).","journal-title":"BMC Urol."},{"key":"992_CR71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","volume":"76","author":"TT Shah","year":"2019","unstructured":"Shah, T. T. et al. Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry. Eur. Urol. 76, 98\u2013105 (2019).","journal-title":"Eur. Urol."},{"key":"992_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/MOU.0b013e32835d9e94","volume":"23","author":"JA Coleman","year":"2013","unstructured":"Coleman, J. A. & Scardino, P. T. Targeted prostate cancer ablation: energy options. Curr. Opin. Urol. 23, 123\u2013128 (2013).","journal-title":"Curr. Opin. Urol."},{"key":"992_CR73","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MOU.0000000000000160","volume":"25","author":"S Ghai","year":"2015","unstructured":"Ghai, S. & Trachtenberg, J. In-bore MRI interventions: current status and future applications. Curr. Opin. Urol. 25, 205\u2013211 (2015).","journal-title":"Curr. Opin. Urol."},{"key":"992_CR74","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/life12020302","volume":"12","author":"Y Wimper","year":"2022","unstructured":"Wimper, Y., F\u00fctterer, J. J. & Bomers, J. G. MR imaging in real time guiding of therapies in prostate cancer. Life 12, 302 (2022).","journal-title":"Life"},{"key":"992_CR75","doi-asserted-by":"crossref","unstructured":"Rubinsky, B., Onik, G. & Mikus, P. Irreversible electroporation: a new ablation modality \u2014 clinical implications. Technol. Cancer Res. Treat. 6, 37\u201348.","DOI":"10.1177\/153303460700600106"},{"key":"992_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/iju.iju_370_23","volume":"40","author":"P Prabhakar","year":"2024","unstructured":"Prabhakar, P. et al. Irreversible electroporation as a focal therapy for localized prostate cancer: a systematic review. Indian. J. Urol. 40, 6\u201316 (2024).","journal-title":"Indian. J. Urol."},{"key":"992_CR77","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00345-018-2281-z","volume":"36","author":"MJ Scheltema","year":"2018","unstructured":"Scheltema, M. J. et al. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. World J. Urol. 36, 1383\u20131389 (2018).","journal-title":"World J. Urol."},{"key":"992_CR78","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/bju.13785","volume":"119","author":"A Villers","year":"2017","unstructured":"Villers, A. et al. Robot\u2010assisted partial prostatectomy for anterior prostate cancer: a step\u2010by\u2010step guide. BJU Int. 119, 968\u2013974 (2017).","journal-title":"BJU Int."},{"key":"992_CR79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.euros.2023.07.001","volume":"55","author":"A Villers","year":"2023","unstructured":"Villers, A. et al. Robot partial prostatectomy for anterior cancer: long-term functional and oncological outcomes at 7 years. Eur. Urol. Open Sci. 55, 11\u201314 (2023).","journal-title":"Eur. Urol. Open Sci."},{"key":"992_CR80","unstructured":"European Association of Urology. Prostate Cancer. EAU Guidelines 2024. EAU https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/treatment (2024)."},{"key":"992_CR81","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1200\/JCO.2014.57.7510","volume":"33","author":"MD Mason","year":"2015","unstructured":"Mason, M. D. et al. Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer. J. Clin. Oncol. 33, 2143\u20132150 (2015).","journal-title":"J. Clin. Oncol."},{"key":"992_CR82","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","volume":"67","author":"MJ Zelefsky","year":"2007","unstructured":"Zelefsky, M. J. et al. Multi-institutional analysis of long-term outcome for stages T1\u2013T2 prostate cancer treated with permanent seed implantation. Int. J. Radiat. Oncol. Biol. Phys. 67, 327\u2013333 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"992_CR83","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5114\/jcb.2017.69809","volume":"9","author":"A Haworth","year":"2017","unstructured":"Haworth, A. & Williams, S. Focal therapy for prostate cancer: the technical challenges. J. Contemp. Brachytherapy 9, 383\u2013389 (2017).","journal-title":"J. Contemp. Brachytherapy"},{"key":"992_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1449-z","volume":"15","author":"C Meynard","year":"2020","unstructured":"Meynard, C. et al. Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers. Radiat. Oncol. 15, 1 (2020).","journal-title":"Radiat. Oncol."},{"key":"992_CR85","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","volume":"59","author":"L Dickinson","year":"2011","unstructured":"Dickinson, L. et al.\u00a0Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur. Urol. 59, 477\u2013494 (2011).","journal-title":"Eur. Urol."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-024-00992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-024-00992-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-024-00992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:13:52Z","timestamp":1751631232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-024-00992-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1038\/s41585-024-00992-7","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"18 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}